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Cardiovascular diseases are not only the leading causes of mortality in Hungary but also
the mortality rate is twice as high as the European Union average, so screening pro-
grammes identifying subjects with elevated blood pressure (BP) are of utmost impor-
tance. May Measurement Month (MMM) is an annual global initiative that began in 2017
aimed at raising awareness of high BP. Hungary joined the 3rd campaign of MMM in 2019
and an overview of the results are presented in this paper. An opportunistic cross-
sectional survey of participants aged18years was carried out in May 2019. Hypertension
was defined as systolic BP 140 mmHg and diastolic BP 90 mmHg or treatment for hy-
pertension, statistical analysis followed the standard MMM protocol. In Hungary, 55 sites
were set up in primary and secondary care facilities, in pharmacies, and in malls across all
regions, in both cities and villages. Out of 2766 individuals screened, 1286 participants
(46.5%) had hypertension. Out of 1869 participants not on antihypertensive medication,
389 (20.8%) had elevated BP. In the case of treated individuals (n¼ 897), 420 (46.8%) had
uncontrolled hypertension. Almost every 2nd subject of the screened cohort had hyper-
tension (treated and controlled, treated and uncontrolled, or untreated). In the
untreated cohort, every 5th subject had elevated BP, whilst among patients on antihyper-
tensive medication, every second had uncontrolled BP. By identifying almost one-third of
the whole screened cohort with the possibility of newly diagnosed or uncontrolled hyper-
tension, our results confirm the importance of BP screening campaigns.
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Introduction
Cardiovascular (CV) diseases are the leading causes of mor-
tality in Hungary. Between 2000 and 2012 CV mortality in
both sexes decreased by about 30% in both age categories
of 40–59 and 60–79 years, attributed to the reduction in the
number of other ischaemic heart diseases and of other
ischaemic heart diseases plus stroke, respectively.1
However, compared with other European Union countries
the mortality risk in Hungary is still very high. In 2017,
Hungary was among the top four European Union countries
with Lithuania, Latvia, and Slovakia in respect of ischaemic
heart disease mortality with 286/100 000 deaths/year.
Stroke mortality rates in Hungary are also amongst the
highest in the European Union with values of 178/100 000
deaths/year in men and 127/100 000 deaths/year in
women.2
The early diagnosis and the proper treatment of hyper-
tension, as a major contributor to cardiovascular disease
(CVD) mortality merits a high priority to improve the CV
outcome of the Hungarian citizens. That is why the
Hungarian Society of Hypertension had decided in 2017 to
join May Measurement Month (MMM), the hypertension
awareness campaign from the International Society of
Hypertension (ISH). In the 1st year, 3967 subjects were in-
volved and 2052 (51.8%) of them had hypertension. By
identifying almost one-third of the screened cohort with
the possibility of newly diagnosed or uncontrolled hyper-
tension, the Hungarian data of MMM17 confirmed the im-
portance of hypertension screening campaigns.3 This
publication provides the Hungarian data of MMM19.
Methods
May Measurement Month is a cross-sectional survey
planned and distributed worldwide by the ISH. The
Hungarian co-ordinator was Zoltán Járai, the president of
the Hungarian Society of Hypertension.
Prior to participation, all patients gave written informed
consent. The study was approved by the Scientific and
Research Ethics Committee of the Medical Research
Council, the Hungarian Ministry of Health (ETT TUKEB
18736-2/2019/EKU) and was carried out in accordance
with the tenets of the Declaration of Helsinki.
The survey was performed following the instructions
from the ISH.4 Sites were set up in primary and secondary
care facilities, in pharmacies, and occasionally in shopping
malls. Altogether 55 sites were involved. Target subjects
were adult volunteers (18years), who ideally, had not
had their blood pressure (BP) measured in the previous
year, but subjects were not excluded on this basis.
Site leader physicians and assistants were recruited and
trained by the Hungarian Society of Hypertension. The
campaign was promoted by scientific newsletters of the so-
ciety and through social media. Before the BP measure-
ment, race and history of hypertension, diabetes, smoking,
previous myocardial infarction, stroke, smoking, and alco-
hol consumptionwere recorded alsowith the data of height
and weight. Number of antihypertensive medications, the
regular use of statin or aspirin were also registered.
Recommendation for standard methods included the mea-
surement of brachial circumference for appropriate cuff
size usage; left side measurement preferably; at least 5
min resting before measurements in the seated position;
prohibition of smoking before and during the measure-
ment; three consecutive measurements 1 min apart and
the usage of automated oscillometric upper-arm cuff de-
vice preferably. The type of device was not registered.
From the three registered BP values, the mean of the 2nd
and 3rd was used in the calculations. Weight and height
were asked to be also recorded for all patients either based
on measurement or estimation by the subject. No addi-
tional measurements were in the protocol. Screening took
place between 1st of May and 31st of May 2019.
From the 55 sites, datawere uploaded online to the web-
site of the MMM international co-ordinators or were col-
lected by the headquarters of the Hungarian Society of
Hypertension and without local cleaning were directly
transferred to the MMM central statistical team. For those
participants missing either the 2nd or 3rd BP measurement
(or both), multiple imputations using chained equations
were used to estimate the missing reading based on global
data, to provide better comparison across all participants.
Data were analysed centrally by the MMM project team.4
Results
In total, 2766 Caucasian subjects were involved, the mean
age was 47.8 (SD: 6 17.4) years. As data collection was in-
complete for some of the variables in the study question-
naire, numbers used in different analyses vary.
Women were represented in higher proportion than men
(n¼ 1681, 60.8% and n¼ 1084, 39.2%, respectively). Eight
hundred and ninety-seven (32.4%) of the subjects were on
ongoing antihypertensive medication. Two hundred and
forty-five (8.9%) people of the whole cohort had diabetes,
80 (2.9%) had previous myocardial infarction, and 72 (2.6%)
of them suffered stroke previously. Twenty women (1.2%)
were pregnant at the time of the screening and 90 women
(5.4%) reported hypertension in a previous pregnancy. Six
hundred and sixty (23.9%) subjects were current smokers
and 348 (12.6%) reported the consumption of alcohol once
or more per week. The mean body mass index was 26.9kg/
m2.
In respect of the BP statistics in the whole cohort, the
mean BP was 128.5/80.2mmHg. In those patients who
were not on antihypertensive medication, the mean BP
was 125.7/79.6mmHg, while in those, who were on antihy-
pertensive medication, it was 136.9/83.2mmHg.
Considering 140/90mmHg as the threshold for BP control,
1286 (46.5%) of the subjects had controlled or uncontrolled
hypertension. Among those patients who were not receiv-
ing antihypertensive medication (n¼ 1869), 389 (20.8%)
were hypertensive. In case of treated hypertensive
patients (n¼ 897), 420 (46.8%) of them had uncontrolled
BP.
After adjustment for age and sex, significantly higher
systolic and diastolic BPs were found in subjects with
known hypertension and those receiving antihypertensive
medication, while systolic BP was significantly higher in
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those with a diagnosis of diabetes (Supplementary material
online, Figure S1). Compared with those of healthy weight,
overweight, and obese participants had significantly higher
systolic and diastolic BPs (Supplementary material online,
Figure S2).
Discussion
As part of MMM 2019, a standardized multinational screen-
ing campaign of hypertension, 2766 subjects were
screened in Hungary. More than half of the whole cohort
had hypertension (treated or untreated). Every 5th
untreated participant had elevated BP and almost every
2nd participant taking antihypertensive therapy had
uncontrolled BP.
By identifying 809 subjects with the possibility of newly
diagnosed or uncontrolled hypertension, which was 29.2%
of the whole screened cohort, the Hungarian part of
MMM19 once again demonstrated the important role of
screening hypertension for primary and secondary preven-
tion. With this number, the results of MMM17 were almost
exactly reproduced, where this proportion was 30.2%.3
In Hungary, since 2010 a unique national CV screening
programme is ongoing. A specially furnished lorry is moving
throughout the country, in which different examinations
are carried out. At the end of 2017, the screening truck had
been to 1505 places, 135 879 people had participated in
comprehensive screening and 124 557 people had relevant
BP measurement, with 11 601 successful measurements in
2017.5 In 2017, among those patients who reported being
healthy, BP was elevated in 24.2% of women and in 39.2% of
men. In patients with a history of hypertension, BP was
uncontrolled in 55.2% and 63.8% in women and men, re-
spectively. We suppose that the comparison of these results
with the Hungarian MMM19 findings is inappropriate be-
cause of the divergent screening sites of MMM19. However,
it is obvious that despite the relatively low number of sub-
jects with abnormal BP in MMM19, a large proportion of the
screened people was still found to be in the high BP range.
There are also some limitations when interpreting the
results of the MMM screening campaign, as subjects were
not randomly sampled, and samples are therefore not
nationally representative. Furthermore, without further
follow-up examinations of the BP, the proportion of white-
coat and masked hypertension of the screened cohort is
unknown.
In conclusion, the results of MMM19, in line with MMM17,
point out the importance of hypertension screening at the
population level in Hungary. Such campaigns can increase
the awareness of hypertension that can lead to the im-
provement of CVoutcome.
Supplementary material
Supplementary material is available at European Heart
Journal Supplements online.
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results of 2010–2017 specially to hypertension. Hypertonia Nephrol
2018;22:14–19.
B72 J. Nemcsik et al.
